Vincent Parisi

[Vincent Parisi @VincentParisi10]

@VHeart27989 That would make too much sense so probably not

[Vincent Parisi @VincentParisi10]

@newmork I haven't sold, but i think everyone is wondering why they did the offering now at a depressed valuation. Could have given it a few months to see if the price recovered a bit before offering as much as they did. Leads to speculation around additional delays, negative CMC, etc..

[Vincent Parisi @VincentParisi10]

@abracabrasian Cash overhang is gone but that's a brutal raise price. You'd think they could've managed high 50's at least lol.

[Vincent Parisi @VincentParisi10]

@charle77238 Feel like this news would've come out by now with how much backlash they've been facing since the first reported one. You'd think additional deaths would also be disclosed during the recent independent DMC review. With that said, its been trading as if more bad news is coming...

[Vincent Parisi @VincentParisi10]

@JAYSISODIA2 @bio_report Worth noting is that the entire biotech index has been selling off hard. Possible No or delay with EU, but it's not like its only Sarepta that's dropping. Lots of fear....